Clinical, Inflammatory, and Economic Impact of Dextran 70 in Treating Spontaneous Bacterial Peritonitis

NCT00570960 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped drug product became unavilable

Conditions

Spontaneous Bacterial Peritonitis

Interventions

DRUG: Dextran 70
BIOLOGICAL: human albumin

Sponsor

University of Virginia

Collaborators

[object Object]